T Cell Vaccination in Patients With Progressive Multiple Sclerosis

NCT01448252 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

BIOLOGICAL: multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides)
BIOLOGICAL: T cell vaccination

Sponsor

Hadassah Medical Organization